Truqap is a kinase inhibitor that works by blocking pathways that aid the cancer cells survive and mature, so decreases cancer progress. Truqap is from a class of medicines termed an AKT inhibitor. Truqap been given FDA acceptance on November seventeen, 2023, right after beneficial success from the CAPItello-291 Section https://robertn777alw0.ageeksblog.com/profile